Home
>
National Drug Code (NDC)
>
Clindagel
Clindagel - 0299-4500-75 - (clindamycin phosphate)
Drug Information of Clindagel
| Product NDC: | 0299-4500 |
| Proprietary Name: | Clindagel |
| Non Proprietary Name: | clindamycin phosphate |
| Active Ingredient(s): | 10 mg/mL & nbsp; clindamycin phosphate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Clindagel
| Product NDC: | 0299-4500 |
| Labeler Name: | Galderma Laboratories, L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050782 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001127 |
Package Information of Clindagel
| Package NDC: | 0299-4500-75 |
| Package Description: | 75 mL in 1 BOTTLE (0299-4500-75) |
NDC Information of Clindagel
| NDC Code | 0299-4500-75 |
| Proprietary Name | Clindagel |
| Package Description | 75 mL in 1 BOTTLE (0299-4500-75) |
| Product NDC | 0299-4500 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clindamycin phosphate |
| Dosage Form Name | GEL |
| Route Name | TOPICAL |
| Start Marketing Date | 20001127 |
| Marketing Category Name | NDA |
| Labeler Name | Galderma Laboratories, L.P. |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |
